Rodas R A, Erkman-Balis B, Cahill D W
Neurosurgery. 1986 Oct;19(4):622-7. doi: 10.1227/00006123-198610000-00020.
Review of the literature reveals much disparity regarding the incidence, natural history, and survival rate in patients harboring esthesioneuroblastoma (olfactory neuroblastoma). The metastatic tendencies of this tumor have been highly variable in the literature, and reported intracranial involvement has been via local extension from the tumor's origin near the cribriform plate. Our present case describes a metastasis of esthesioneuroblastoma to the right parietal cortex and meninges in a patient without evidence of local recurrence after combined surgical and radiation therapy 5 years previously. The broad spectrum of biological behavior of this tumor, and its response to various therapies are discussed. The immunohistochemical and ultrastructural features of this unusual tumor are also presented. Recommendations are made for the management of these patients, including regular serial neurological examinations, serial computed axial tomography or magnetic resonance imaging of the head and neck, and, in the initial management, chemotherapy.
文献回顾显示,在患有嗅神经母细胞瘤(嗅觉神经母细胞瘤)的患者中,关于发病率、自然病史和生存率存在很大差异。该肿瘤的转移倾向在文献中差异很大,并且报道的颅内受累是通过肿瘤起源于筛板附近的局部扩展。我们目前的病例描述了一名嗅神经母细胞瘤转移至右侧顶叶皮质和脑膜的患者,该患者在5年前接受手术和放疗联合治疗后无局部复发证据。本文讨论了该肿瘤广泛的生物学行为及其对各种治疗的反应。还介绍了这种罕见肿瘤的免疫组织化学和超微结构特征。针对这些患者的管理提出了建议,包括定期进行系列神经学检查、对头颈部进行系列计算机断层扫描或磁共振成像,以及在初始治疗中进行化疗。